Harpoon Therapeutics, Inc. Development Agreements
4 Contracts & Agreements
- Side Letter Amendment to Development and Option Agreement between the Registrant and AbbVie Biotechnology Ltd., dated April 15, 2020 (Filed With SEC on August 5, 2020)
- First Amendment to the Development and Option Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of April 21, 2020 (Filed With SEC on August 5, 2020)
- Development and Option Agreement between the Registrant and AbbVie Biotechnology Ltd., dated as of November 20, 2019 (Filed With SEC on March 12, 2020)
- Development and Manufacturing Services Agreement between the Registrant and CMC ICOS Biologics, Inc., dated July 5, 2016 (Filed With SEC on December 27, 2018)